BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33079640
Number of visits today
1835
Number of downloads
16281849
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Yang X, Qiang Q, Li N, Feng P, Wei W, Hölscher C. Neuroprotective Mechanisms of Glucagon-Like Peptide-1-Based Therapies in Ischemic Stroke: An Update Based on Preclinical Research. Front Neurol 2022;13:844697. [PMID: 35370875 DOI: 10.3389/fneur.2022.844697] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Hammoud R, Drucker DJ. Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1. Nat Rev Endocrinol 2022. [PMID: 36509857 DOI: 10.1038/s41574-022-00783-3] [Reference Citation Analysis]
2 Singh DD, Shati AA, Alfaifi MY, Elbehairi SEI, Han I, Choi EH, Yadav DK. Development of Dementia in Type 2 Diabetes Patients: Mechanisms of Insulin Resistance and Antidiabetic Drug Development. Cells 2022;11. [PMID: 36497027 DOI: 10.3390/cells11233767] [Reference Citation Analysis]
3 Su Q, Chen Q, Li Z, Zhao J, Li L, Xu L, Yang B, Liu C. Multi-omics analysis reveals GABAergic dysfunction after traumatic brainstem injury in rats. Front Neurosci 2022;16:1003300. [PMID: 36507346 DOI: 10.3389/fnins.2022.1003300] [Reference Citation Analysis]
4 Yang X, Feng P, Ji R, Ren Y, Wei W, Hölscher C. Therapeutic application of GLP-1 and GIP receptor agonists in Parkinson's disease. Expert Opin Ther Targets 2022. [PMID: 35584372 DOI: 10.1080/14728222.2022.2079492] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345